TigerConnect® Named a Leader in the 2023 Gartner® Magic Quadrant™ for Clinical Communication and Collaboration

TigerConnect, healthcare’s most trusted clinical collaboration platform, today announced it has been named a Leader in the 2023 Gartner Magic Quadrant for Clinical Communication and Collaboration (CC&C). The evaluation was based on inclusion criteria that included platforms’ competitive product offerings…

Read MoreTigerConnect® Named a Leader in the 2023 Gartner® Magic Quadrant™ for Clinical Communication and Collaboration

Tivic Health Announces Pricing of $1.4 Million Public Offering of Common Stock

Tivic Health® Systems, Inc. (“Tivic”, “Company”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced the pricing of its previously announced public offering of 33,173,000 shares of its common stock at a public offering price…

Read MoreTivic Health Announces Pricing of $1.4 Million Public Offering of Common Stock

FDA Approves ZURZUVAE™ (zuranolone), the First and Only Oral Treatment Approved for Women with Postpartum Depression, and Issues a Complete Response Letter for Major Depressive Disorder

Sage Therapeutics, Inc. (Nasdaq: SAGE) and Biogen Inc. (Nasdaq: BIIB) announced the U.S. Food and Drug Administration (FDA) approved ZURZUVAETM (zuranolone) 50 mg for adults with postpartum depression (PPD). ZURZUVAE is the first and only oral, once-daily, 14-day treatment that can provide rapid…

Read MoreFDA Approves ZURZUVAE™ (zuranolone), the First and Only Oral Treatment Approved for Women with Postpartum Depression, and Issues a Complete Response Letter for Major Depressive Disorder

United States Direct-To-Consumer Genetic Testing Market Analysis Report 2023-2028: Personalized Genetic Testing Services Fuels Market Expansion – ResearchAndMarkets.com

The United States Direct-To-Consumer Genetic Testing Market is expected to grow at a significant rate to 2028 During the forecast period, rising public awareness of the accessibility of direct-to-consumer genetic tests in both developed and developing countries will fuel market…

Read MoreUnited States Direct-To-Consumer Genetic Testing Market Analysis Report 2023-2028: Personalized Genetic Testing Services Fuels Market Expansion – ResearchAndMarkets.com

MicroVention Celebrates One-Year Anniversary of FRED™ X Flow Diverter with Over 1,000 Patients Treated Across the U.S.

MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, is celebrating the one-year anniversary of the company’s FRED™ X Flow Diverter. In close collaboration with physician partners across the United States, over 1,000 patients have been…

Read MoreMicroVention Celebrates One-Year Anniversary of FRED™ X Flow Diverter with Over 1,000 Patients Treated Across the U.S.